Clarity Pharmaceuticals Ltd.ASX: CU6

IND approval from the FDA for theranostic SAR-Bombesin trial

Nov 21, 2022 at 4:11 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment